IMPORTANCE
Cardiac magnetic resonance (CMR) imaging can identify unrecognized
myocardial infarction (UMI) in the general population. Unrecognized
myocardial infarction by CMR portends poor prognosis in the short term but,
to our knowledge, long-term outcomes are not known.
OBJECTIVE
To determine the long-term outcomes of UMI by CMR compared with
clinically recognized myocardial infarction (RMI) and no myocardial
infarction (MI).
DESIGN, SETTING, AND PARTICIPANTS
Participants of the population-based, prospectively enrolled ICELAND
MI cohort study (aged 67–93 years) were characterized with CMR at
baseline (from January 2004-January 2007) and followed up for up to 13.3
years. Kaplan-Meier time-to-event analyses and a Cox regression were used to
assess the association of UMI at baseline with death and future
cardiovascular events.
MAIN OUTCOMES AND MEASURES
The primary outcome was all-cause mortality. Secondary outcomes were
a composite of major adverse cardiac events (MACE: death, nonfatal MI, and
heart failure).
RESULTS
Of 935 participants, 452 (48.3%) were men; the mean (SD) age of
participants with no MI, UMI, and RMI was 75.6 (5.3) years, 76.8 (5.2)
years, and 76.8 (4.7) years, respectively. At 3 years, UMI and no MI
mortality rates were similar (3%) and lower than RMI rates (9%).At 5 years,
UMI mortality rates (13%) increased and were higher than no MI rates (8%)
but still lower than RMI rates (19%). By 10 years, UMI and RMI mortality
rates (49% and 51%, respectively) were not statistically different; both
were significantly higher than no MI (30%) (P <.001). After adjusting
for age, sex, and diabetes, UMI by CMR had an increased risk of death
(hazard ratio [HR], 1.61; 95% CI, 1.27–2.04), MACE (HR, 1.56; 95% CI,
1.26–1.93), MI (HR, 2.09; 95% CI, 1.45–3.03), and heart
failure (HR, 1.52; 95% CI, 1.09–2.14) compared with no MI and
statistically nondifferent risk of death (HR, 0.99; 95% CI,
0.71–1.38) and MACE (HR, 1.23; 95% CI, 0.91–1.66) vs RMI.
CONCLUSIONS AND RELEVANCE
In this study, all-cause mortality of UMI was higher than no MI, but
within 10 years from baseline evaluation was equivalent with RMI.
Unrecognized MI was also associated with an elevated risk of nonfatal MI and
heart failure. Whether secondary prevention can alter the prognosis of UMI
will require prospective testing.